MOTS-c Levels and Sarcopenia Risk in Chronic Peritoneal Dialysis Patients: A Pilot Study.

Medicina (Kaunas) · 2025 · PMC11857303 · PMID 40005438

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

barely significantp = 0.09so close (0.05 < p ≤ 0.1)

On top of this, a barely significant difference in the d/sMOTS-c clearance ( p = 0.09) emerged between patients on CAPD or APD. 3.3.

also in 875 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.